How is BPC-157 dosed?

Where the convention figures came from

The animal research literature generally works at 2.5–3.75 mcg per kilogram twice daily. Applied to an adult human body weight that arithmetic lands somewhere around 300–400 mcg per day, which is the neighbourhood the commonly cited 250 and 500 mcg figures occupy. So the convention is not arbitrary — it is a species extrapolation, and knowing that is more useful than either accepting the number or dismissing it.

What the extrapolation assumes is the part worth examining. Scaling a dose from rat to human by body weight alone assumes comparable absorption, distribution, metabolism and clearance between the species, and comparable sensitivity at the receptor. Regulatory pharmacology generally uses body-surface-area scaling rather than a straight per-kilogram conversion precisely because the simple version tends to overshoot. Nobody has run the study that would settle which applies here.

The half-life complication

Plasma half-life is under 30 minutes, which on its own would imply a compound cleared long before any daily interval could matter. The reported biological effects nonetheless outlast plasma clearance, and the usual explanation is local tissue activity and downstream changes in gene expression rather than circulating concentration. That explanation is plausible and it is not established. It also means the ordinary logic connecting half-life to dosing interval — the logic that makes weekly incretin dosing coherent — does not straightforwardly apply, so the frequency conventions are not derivable from the pharmacokinetics either.

Route, and why it splits by application

Two routes appear in the literature and in practice. Subcutaneous injection is used in the musculoskeletal work, and localised injection near the injury site is reported as more effective than a distant site in those models. Oral administration appears in the gastrointestinal work, and it is coherent there for a specific reason: BPC-157's stability in gastric acid lets it reach gut tissue intact. The split is not a preference — it follows the tissue being studied.

What an honest answer looks like

An answer here has to carry two things at once: that the trial record fixes no figure, and what the circulating figures are together with where they came from. Both halves are load-bearing. Give only the absence and a reader who meets 250 mcg on the next site has no way to place it; give only the number and it acquires an authority no study ever conferred on it.

To convert any of these microgram figures into syringe units for a given vial and volume, use the dosage calculator.